Navigation Links
Sequella Obtains Funding to Continue Expansion of its Anti-infectives Pipeline
Date:10/12/2009

ROCKVILLE, Md., Oct. 12 /PRNewswire/ -- Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it received a $594,661 two-year Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) for the development of SQ641, Sequella's lead compound in its capuramycin series, a new class of antibiotic.

The Phase 1 SBIR grant will support studies with SQ641 to investigate activity against several different Mycobacterium avium complex and Mycobacterium abscessus strains in white blood cells in vitro and in animal models. These studies will measure SQ641 activity against clinically important NTM pathogens in anticipation of potential advancement to Investigational New Drug (IND)-directed preclinical studies.

"There are few effective drugs currently available to treat NTM-related infections," said Dr. Carol Nacy, CEO of Sequella, "and these infections are increasing dramatically in the U.S., nearly 5% per year from 1998 to 2007. New infections were reported not only in immunocompromised individuals, as has been seen in the past, but also in a significant and rising number of patients with intact immune systems. New and more potent drugs will be required to treat these bacteria, ubiquitous in water and soil, as they are now posing a threat to everyone."

About SQ641

SQ641 is the lead drug candidate from a 7000-compound library of semi-synthetic translocase 1 (TL-1) inhibitors developed as potential treatments for mycobacterial diseases or bacterial pneumonia (Streptococcus pneumoniae). TL-1 is a unique antibacterial target, an enzyme required for cell wall synthesis in all bacteria. SQ641 possesses exceptional activity against all members of the Mycobacteria family of bacteri
'/>"/>

SOURCE Sequella, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sequella Commences Phase 1B Study for New Tuberculosis Drug SQ109
2. Infectious Diseases Company, Sequella, to Present at Upcoming European Conferences
3. Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609
4. Sequella Lead Drug Compound SQ109 Receives Orphan Drug Status From the US FDA and Orphan Medicinal Product Designation From the European Medicines Agency for the Treatment of Tuberculosis
5. Tianyin Pharmaceutical Co., Inc. Obtains GMP Certification for Its New Production Facility
6. Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine
7. Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government
8. Sinovac Obtains Production License for H1N1 Vaccine
9. Blackrock Microsystems Obtains Expanded 510(k) to Market NeuroPort System
10. China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs
11. NeoStem Obtains Exclusive License to Innovative Stem Cell Procedure Treating Musculoskeletal Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... cell phones to cars and flashlights, batteries play ... technology companies constantly are seeking ways to improve ... time using a water-based solution, researchers at the ... more efficient nuclear battery that could be used ... source in automobiles and also in complicated applications ...
(Date:9/16/2014)... BlueInGreen® , a water ... for delivering dissolved gases into liquids, announced the ... a manufacturer’s representative firm to its sales network. ... municipal water and wastewater applications in the Canadian ... founded in 1992 and serves Quebec and Ontario ...
(Date:9/16/2014)... MILLBROOK, N.Y. , Sept. 16, 2014  Donald Fresne, ... the appointment of Stephan Vagner , PhD to its ... the University of Toulouse, France , performed ... Germany , and at Inserm, the French institute of ... Inserm and works both at the Curie Institute, Orsay, ...
(Date:9/16/2014)... , Sept. 16, 2014  The Council ... entrepreneurial support organization in the country, today released ... Report . It showed that ... North Carolina startups in the technology, ... more global investment from a variety of sources. Significant ...
Breaking Biology Technology:BlueInGreen® Expands into Canada – Signs Representative Agreement with H2Flow Equipment Inc. 2New Appointment to the Scientific Advisory Committee at Egenix, Inc. 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 3CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 4
... led by Governor Doyle and organized by Forward Wisconsin ... industrys leading conference with goals to establish new partnerships, ... community and to let others know that Wisconsin has ... group, the delegation met its objectives in spite of ...
... Medical Systems, a unit of General Electric Company, announced ... Food and Drug Administration to begin marketing its new ... Signa EXCITE 3.0T combines the increased speed and higher ... of imaging capabilities found on premium 1.5 Tesla systems. ...
... Insurance. Motorcycles? Computerworld has just released their ... 2003, and five Wisconsin companies have placed in the ... Inc. of Milwaukee. , ,This years list, with ... employees perspectives of working conditions and employment benefits. According ...
Cached Biology Technology:On site at BIO 2003 2On site at BIO 2003 3On site at BIO 2003 4On site at BIO 2003 5GE Medical Systems Receives FDA Clearance for New MRI System 2Wisconsin Companies Ranked Top in Nation in IT 2Wisconsin Companies Ranked Top in Nation in IT 3Wisconsin Companies Ranked Top in Nation in IT 4
(Date:9/16/2014)... Spanish . CRG ... the Journal of Cell Biology describes how Topo ... division , At this very moment thousands of our body,s ... which the body repairs damaged tissues and regenerates others like ... as "mitosis", during which the cell duplicates its genetic material ...
(Date:9/16/2014)... vital functions in an organism. For example, they ... and control immune system responses. Researchers established some ... of each other, but instead form complex networks. ... find many similarities with online social networks," says ... Systems Biology. "Some proteins are good networkers that ...
(Date:9/16/2014)... , Sept. 16, 2014 As open ... make important decisions about their 2015 benefits. According to ... health solutions business of Aon plc (NYSE: ... take a more proactive role in managing their health ... than ever for individuals to understand how they can ...
Breaking Biology News(10 mins):Unraveling cell division 2Unraveling cell division 3Good networkers make prime targets 2Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 2Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 3Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 4Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 5Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 6Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 7
... , EAST LANSING, Mich. Bacteria infections most of ... world and not malaria are the leading cause of ... new Michigan State University project based in Nigeria and funded ... diseases by collecting local data on the ailments, spurring vaccine ...
... European Molecular Biology Laboratory (EMBL) in Monterotondo, is one ... honoured with a Howard Hughes Medical Institute (HHMI) International ... for five years, is designed to give a boost ... United States. The award recognises the potential of Sotillo,s ...
... concern that excessive levels of fructose may pose a great health ... researchers at the University of Colorado School of Medicine, along with ... if two common sweeteners in western diets differ in their effects ... The study, recently published in the journal Metabolism , took ...
Cached Biology News:$5.8 million Gates grant targets child-killing bacteria diseases in Africa 2CU School of Medicine researchers look at effects of 2 common sweeteners on the body 2
Rad 50 Immunogen: c-terminal mRad 50 (604 amino acids). Storage: 4 C...
...
... Kit Includes: Sufficient library for ... x 10^9 independent sequences, -28 gIII ... DNA sequencing, -96 gIII Sequencing Primer ... Host E. coli strain ER2738, Control ...
... The CHEMICON Re-Blot Western Blot Recycling ... antibodies from Western blots that have ... iodine or other isotopes. It is ... (TMB, DAB, 4-chloronapthol, etc.), as it ...
Biology Products: